Triglyceride level, aldosterone level and subclinical atherosclerosis in patient with coronary heart disease in combination with nonalcoholic fatty liver disease

Triglyceride Level ◽

Fatty Liver Disease ◽

Subclinical Atherosclerosis ◽

Aldosterone Level ◽

Subclinical Atherosclerosis, Echocardiographic Ranges, Level Of Transaminase In Patients With Coronary Heart Disease With Preserved Ejection Fraction Combined With Nonalcoholic Fatty Liver Disease.

Atherosclerosis ◽

10.1016/j.atherosclerosis.2019.06.480 ◽

2019 ◽

Vol 287 ◽

pp. e159-e160

Author(s):

M. Grechanyk ◽

O. Kuryata

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Liver Disease ◽

Ejection Fraction ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Subclinical Atherosclerosis ◽

Preserved Ejection Fraction ◽

Screening of nonalcoholic fatty liver disease in patients with coronary heart disease by transient elastography: proceed with caution

Wiener klinische Wochenschrift ◽

10.1007/s00508-014-0621-6 ◽

2014 ◽

Vol 127 (1-2) ◽

pp. 75-76

Author(s):

Masato Yoneda ◽

Kento Imajo ◽

Satoru Saito ◽

Atsushi Nakajima

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Transient Elastography ◽

Severity of nonalcoholic fatty liver disease on sonography and risk of coronary heart disease

Journal of Clinical Ultrasound ◽

10.1002/jcu.22472 ◽

2017 ◽

Vol 45 (7) ◽

pp. 391-399 ◽

Cited By ~ 8

Author(s):

Sun Hwa Lee ◽

Seong Jong Yun ◽

Dong Hyeon Kim ◽

Hyeon Hwan Jo ◽

Yong Sung Park

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

EFFICIENCY OF USING URSODEOXYCHOLIC ACID AND L-ARGININE ON THE BACKGROUND OF BASIC THERAPY IN PATIENTS WITH CORONARY HEART DISEASE, COMORBID WITH NONALCOHOLIC FATTY LIVER DISEASE

Bukovinian Medical Herald ◽

10.24061/2413-0737.xxi.2.82.1.2017.8 ◽

2017 ◽

Vol 21 (2 (82) p.1) ◽

pp. 31-35

Author(s):

N.S. Mykhailovska ◽

L.E. Miniailenko ◽

O.S. Reznik ◽

O.O. Lisova ◽

T.V. Oliinyk

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Liver Disease ◽

Fatty Liver ◽

Ursodeoxycholic Acid ◽

Fatty Liver Disease ◽

Basic Therapy

Coronary heart disease is associated with nonalcoholic fatty liver disease in patients without hypertension and diabetes

Medicine ◽

10.1097/md.0000000000020898 ◽

2020 ◽

Vol 99 (26) ◽

pp. e20898

Author(s):

Zipeng Liu ◽

Rufeng Wei ◽

Yan Li

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

P203Triglicerid level, atherosklerosis of the carotid arteries and inflammation in patient with coronary heart disease in combination with nonalcoholic fatty liver disease

Cardiovascular Research ◽

10.1093/cvr/cvu082.137 ◽

2014 ◽

Vol 103 (suppl 1) ◽

pp. S36.2-S36

Author(s):

M Grechanyk ◽

OV Kuryata

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Carotid Arteries ◽

Sex-influenced association of nonalcoholic fatty liver disease with coronary heart disease

Atherosclerosis ◽

10.1016/j.atherosclerosis.2013.01.013 ◽

2013 ◽

Vol 227 (2) ◽

pp. 420-424 ◽

Cited By ~ 18

Author(s):

Mary F. Feitosa ◽

Alexander P. Reiner ◽

Mary K. Wojczynski ◽

Mariaelisa Graff ◽

Kari E. North ◽

...

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Family history of coronary heart disease is associated with a higher incidence of nonalcoholic fatty liver disease: Central obesity the likely link

Obesity Research & Clinical Practice ◽

10.1016/j.orcp.2007.03.001 ◽

2007 ◽

Vol 1 (2) ◽

pp. 125-131 ◽

Cited By ~ 3

Author(s):

Lei Zhang ◽

Kui Pu ◽

Zhonglin Chai ◽

John B. Dixon

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Liver Disease ◽

Family History ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Central Obesity ◽

History Of

Diagnostic significance of the newest biomarkers of steatosis progression in patients with stable coronary heart disease, combined with nonalcoholic fatty liver disease

Current issues in pharmacy and medicine science and practice ◽

10.14739/2409-2932.2018.1.123648 ◽

2018 ◽

Vol 0 (1) ◽

Author(s):

I. I. Vakalyuk ◽

N. G. Virstyuk

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Diagnostic Significance ◽

Stable Coronary Heart Disease

645 The Framingham Risk Score Accurately Predicts the Higher Risk of Coronary Heart Disease in Patients with Nonalcoholic Fatty Liver Disease

Gastroenterology ◽

10.1016/s0016-5085(09)63706-9 ◽

2009 ◽

Vol 136 (5) ◽

pp. A-803 ◽

Cited By ~ 1

Author(s):

Sombat Treeprasertsuk ◽

Paul Angulo ◽

Leon A. Adams ◽

Keith D. Lindor

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Liver Disease ◽

Fatty Liver ◽

Risk Score ◽

Fatty Liver Disease ◽

Framingham Risk Score ◽

Framingham Risk